Founded in early 2005, StratiCELL is a leading company assisting the dermo-cosmetic industry for the safety and efficacy evaluation of their compounds by means of in vitro models and methods.
StratiCELL is unique in its kind, providing an integrated solution for in vitro testing of skin care and dermatology products as StratiCELL manufactures in house the in vitro skin models and offers the laboratory testing services as well. StratiCELL also performs biological activity testing on monolayer cell cultures (keratinocytes, fibroblasts, melanocytes, etc) and on human ex vivo skin collected from abdominal or breast surgery.
StratiCELL aims to ensure the most up-to-date in vitro solutions at the highest scientific standards, with a state-of-the-art equipments and technology platforms including cell culture facilities, histology, real-time qPCR & TaqMan arrays, protein chemistry, immunoassays, fluorescence microscopy, Franz-type diffusion cells, uHPLC-MS/MS, high density DNA microarrays, etc.
The company has a strong international commitment, with 90% of its turnover performed abroad. StratiCELL is accredited "Crédit-Impôts-Recherche" (CIR) by the French Ministery of Education and Research.
StratiCELL laboratories and offices are located within the Crealys Science Park, nearby Brussels at the heart of Europe.
StratiCELL has a strong R&D commitment and continuously develops methods and models to address and support new and innovative claims bringing added value to products.
Based on the know-how in skin biology and its technology platforms, the company participates in several research projects from the EU 7th Framework Program (i.e. NanoValid, Nu-Age, NanoToxClass).